Jim Wassil, CHIEF OPERATING OFFICER at Vaxcyte, Inc. (PCVX), sold 19,778 shares at $116.14 ($2.3M) on 2024-09-16, disclosed to the SEC on 2024-09-18.
Scheduled sale ($2.3M) by CHIEF OPERATING OFFICER under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $115.06 | 1,784 | $205K | 9.0% |
| 2 | $115.06 | 1,784 | $205K | 9.0% |
| 3 | $116.14 | 7,994 | $928K | 40.5% |
| 4 | $116.14 | 7,994 | $928K | 40.5% |
| 5 | $116.96 | 222 | $26K | 1.1% |
| Total | $115.95 avg | 19,778 |
| $2.3M |
| 100% |
| Filing → |
| PCVX | SELL | 2026-09-02 | $212K | — | Filing → |
| PCVX | SELL | 2026-08-05 | $121K | — | Filing → |
| PCVX | SELL | 2026-07-06 | $127K | — | Filing → |